333 related articles for article (PubMed ID: 29958424)
1. Anti-Correlation between the Dynamics of the Active Site Loop and C-Terminal Tail in Relation to the Homodimer Asymmetry of the Mouse Erythroid 5-Aminolevulinate Synthase.
Na I; Catena D; Kong MJ; Ferreira GC; Uversky VN
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29958424
[TBL] [Abstract][Full Text] [Related]
2. Murine erythroid 5-aminolevulinate synthase: Truncation of a disordered N-terminal extension is not detrimental for catalysis.
Stojanovski BM; Breydo L; Uversky VN; Ferreira GC
Biochim Biophys Acta; 2016 May; 1864(5):441-52. PubMed ID: 26854603
[TBL] [Abstract][Full Text] [Related]
3. Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias.
Peoc'h K; Nicolas G; Schmitt C; Mirmiran A; Daher R; Lefebvre T; Gouya L; Karim Z; Puy H
Mol Genet Metab; 2019 Nov; 128(3):190-197. PubMed ID: 30737140
[TBL] [Abstract][Full Text] [Related]
4. Human Erythroid 5-Aminolevulinate Synthase Mutations Associated with X-Linked Protoporphyria Disrupt the Conformational Equilibrium and Enhance Product Release.
Fratz EJ; Clayton J; Hunter GA; Ducamp S; Breydo L; Uversky VN; Deybach JC; Gouya L; Puy H; Ferreira GC
Biochemistry; 2015 Sep; 54(36):5617-31. PubMed ID: 26300302
[TBL] [Abstract][Full Text] [Related]
5. X-linked sideroblastic anemia due to carboxyl-terminal ALAS2 mutations that cause loss of binding to the β-subunit of succinyl-CoA synthetase (SUCLA2).
Bishop DF; Tchaikovskii V; Hoffbrand AV; Fraser ME; Margolis S
J Biol Chem; 2012 Aug; 287(34):28943-55. PubMed ID: 22740690
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of 5-aminolevulinate synthase, the first enzyme of heme biosynthesis, and its link to XLSA in humans.
Astner I; Schulze JO; van den Heuvel J; Jahn D; Schubert WD; Heinz DW
EMBO J; 2005 Sep; 24(18):3166-77. PubMed ID: 16121195
[TBL] [Abstract][Full Text] [Related]
7. Isoniazid inhibits human erythroid 5-aminolevulinate synthase: Molecular mechanism and tolerance study with four X-linked protoporphyria patients.
Fratz-Berilla EJ; Breydo L; Gouya L; Puy H; Uversky VN; Ferreira GC
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):428-439. PubMed ID: 27838491
[TBL] [Abstract][Full Text] [Related]
8. Human aminolevulinate synthase structure reveals a eukaryotic-specific autoinhibitory loop regulating substrate binding and product release.
Bailey HJ; Bezerra GA; Marcero JR; Padhi S; Foster WR; Rembeza E; Roy A; Bishop DF; Desnick RJ; Bulusu G; Dailey HA; Yue WW
Nat Commun; 2020 Jun; 11(1):2813. PubMed ID: 32499479
[TBL] [Abstract][Full Text] [Related]
9. Murine erythroid 5-aminolevulinate synthase: Adenosyl-binding site Lys221 modulates substrate binding and catalysis.
Stojanovski BM; Ferreira GC
FEBS Open Bio; 2015; 5():824-31. PubMed ID: 26605136
[TBL] [Abstract][Full Text] [Related]
10. 5-Aminolevulinate synthase catalysis: The catcher in heme biosynthesis.
Stojanovski BM; Hunter GA; Na I; Uversky VN; Jiang RHY; Ferreira GC
Mol Genet Metab; 2019 Nov; 128(3):178-189. PubMed ID: 31345668
[TBL] [Abstract][Full Text] [Related]
11. Effect of 5-aminolevulinic acid on erythropoiesis: a preclinical in vitro characterization for the treatment of congenital sideroblastic anemia.
Fujiwara T; Okamoto K; Niikuni R; Takahashi K; Okitsu Y; Fukuhara N; Onishi Y; Ishizawa K; Ichinohasama R; Nakamura Y; Nakajima M; Tanaka T; Harigae H
Biochem Biophys Res Commun; 2014 Nov; 454(1):102-8. PubMed ID: 25450364
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathophysiology and genetic mutations in congenital sideroblastic anemia.
Fujiwara T; Harigae H
Free Radic Biol Med; 2019 Mar; 133():179-185. PubMed ID: 30098397
[TBL] [Abstract][Full Text] [Related]
13. Structure of the Mitochondrial Aminolevulinic Acid Synthase, a Key Heme Biosynthetic Enzyme.
Brown BL; Kardon JR; Sauer RT; Baker TA
Structure; 2018 Apr; 26(4):580-589.e4. PubMed ID: 29551290
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics analysis of the structural and dynamic properties of the functionally enhanced hepta-variant of mouse 5-aminolevulinate synthase.
Na I; DeForte S; Stojanovski BM; Ferreira GC; Uversky VN
J Biomol Struct Dyn; 2018 Jan; 36(1):152-165. PubMed ID: 27928941
[TBL] [Abstract][Full Text] [Related]
15. ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria.
To-Figueras J; Ducamp S; Clayton J; Badenas C; Delaby C; Ged C; Lyoumi S; Gouya L; de Verneuil H; Beaumont C; Ferreira GC; Deybach JC; Herrero C; Puy H
Blood; 2011 Aug; 118(6):1443-51. PubMed ID: 21653323
[TBL] [Abstract][Full Text] [Related]
16. GLRX5 mutations impair heme biosynthetic enzymes ALA synthase 2 and ferrochelatase in Human congenital sideroblastic anemia.
Daher R; Mansouri A; Martelli A; Bayart S; Manceau H; Callebaut I; Moulouel B; Gouya L; Puy H; Kannengiesser C; Karim Z
Mol Genet Metab; 2019 Nov; 128(3):342-351. PubMed ID: 30660387
[TBL] [Abstract][Full Text] [Related]
17. 5-aminolevulinate synthase: catalysis of the first step of heme biosynthesis.
Hunter GA; Ferreira GC
Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):102-10. PubMed ID: 19268008
[TBL] [Abstract][Full Text] [Related]
18. [Progress of study on sideroblastic anemia and its possible gene therapy--review].
Wang YQ; Zhu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):524-8. PubMed ID: 15972158
[TBL] [Abstract][Full Text] [Related]
19. Molecular defects of erythroid 5-aminolevulinate synthase in X-linked sideroblastic anemia.
Bottomley SS; May BK; Cox TC; Cotter PD; Bishop DF
J Bioenerg Biomembr; 1995 Apr; 27(2):161-8. PubMed ID: 7592563
[TBL] [Abstract][Full Text] [Related]
20. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.
Cotter PD; May A; Fitzsimons EJ; Houston T; Woodcock BE; al-Sabah AI; Wong L; Bishop DF
J Clin Invest; 1995 Oct; 96(4):2090-6. PubMed ID: 7560104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
